PAGANO, BENEDETTA
 Distribuzione geografica
Continente #
EU - Europa 518
NA - Nord America 456
AS - Asia 86
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.062
Nazione #
US - Stati Uniti d'America 455
IE - Irlanda 175
SE - Svezia 145
IT - Italia 80
CN - Cina 70
PL - Polonia 36
DE - Germania 28
UA - Ucraina 16
BE - Belgio 9
FR - Francia 9
FI - Finlandia 7
GB - Regno Unito 7
IN - India 6
IR - Iran 5
VN - Vietnam 4
AT - Austria 3
EU - Europa 2
RU - Federazione Russa 2
CA - Canada 1
HK - Hong Kong 1
NL - Olanda 1
Totale 1.062
Città #
Dublin 173
Chandler 156
Nyköping 109
Jacksonville 38
Warsaw 36
Ashburn 31
Beijing 30
Princeton 27
Messina 23
Bremen 19
Medford 19
Des Moines 17
Rome 11
Brussels 9
Ann Arbor 8
Cambridge 8
Dearborn 8
Jinan 5
San Mateo 5
Zhengzhou 5
Augusta 4
Dong Ket 4
Redwood City 4
Waverly Hall 4
Ardabil 3
Milan 3
Monmouth Junction 3
Nanchang 3
Nanjing 3
Pune 3
Rometta Marea 3
Santa Domenica 3
Tianjin 3
Torregrotta 3
Vienna 3
Wilmington 3
Boardman 2
Brooklyn 2
Clearwater 2
Hangzhou 2
Leawood 2
New York 2
Ningbo 2
Pleasant Hill 2
Pozzo Di Gotto 2
Pozzuoli 2
Quinto Di Treviso 2
Reggio Calabria 2
Shenyang 2
Taiyuan 2
Taizhou 2
Berlin 1
Castelnuovo Rangone 1
Catania 1
Changsha 1
Chengdu 1
Duncan 1
Edinburgh 1
Guangzhou 1
Haikou 1
Hebei 1
Hefei 1
Helsinki 1
Hong Kong 1
Jian 1
Lancaster 1
London 1
Maple Ridge 1
Meppel 1
Norwalk 1
Palo Alto 1
Pescara 1
Saint Petersburg 1
Santa Teresa Di Riva 1
Shenzhen 1
Stanford 1
Torino 1
Wuhan 1
Totale 846
Nome #
PRRT Retreatments: Renal Function Evaluation 85
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 76
Design and synthesis of acetylcholinesterase inhibitors 65
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 64
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 62
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 62
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 62
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 61
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 60
Renal Function Evaluation in PRRT Retreatments 56
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 54
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 54
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 53
Study of the production yields of 18F, 11C, 13N and 15O positron emitters from plasma-laser proton sources at ELI-Beamlines for labeling of PET radiopharmaceuticals 51
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 51
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 50
Theranosticsin nuclear medicine and oncology 47
Evaluation of the production capabilities of 18F, 11C, 13N and 15O PET isotopes at the PET-cyclotron-radiochemistry site of Messina University 42
Radiopharmaceuticals for Bone Metastases 40
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics 14
Totale 1.109
Categoria #
all - tutte 4.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 3 0
2019/202099 13 4 0 5 0 9 8 7 1 25 9 18
2020/2021184 19 5 46 8 20 10 8 12 8 16 23 9
2021/2022159 2 17 2 5 9 2 4 11 4 14 17 72
2022/2023536 43 76 29 43 44 42 17 18 196 10 14 4
2023/202487 5 16 5 7 13 26 2 13 0 0 0 0
Totale 1.109